These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy. Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells. Zhang Y; Wang Q; Li L; Le Y; Liu L; Yang J; Li Y; Bao G; Yan L J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1205-1216. PubMed ID: 34074193 [TBL] [Abstract][Full Text] [Related]
50. Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents. Allam HA; Aly EE; Farouk AKBAW; El Kerdawy AM; Rashwan E; Abbass SES Bioorg Chem; 2020 May; 98():103726. PubMed ID: 32171987 [TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of novel pyridopyrimidine derivatives with anchoring non-coplanar aromatic extensions of EGFR inhibitory activity. Eissa AAM; Aljamal KFM; Ibrahim HS; Abdelrasheed Allam H Bioorg Chem; 2021 Nov; 116():105318. PubMed ID: 34488123 [TBL] [Abstract][Full Text] [Related]
52. Pyrazole derivatives as potent EGFR inhibitors: synthesis, biological evaluation and Bayoumi NA; El-Shehry MF Future Med Chem; 2022 Dec; 14(23):1755-1769. PubMed ID: 36524436 [No Abstract] [Full Text] [Related]
53. Design, synthesis and molecular modeling studies of 2-styrylquinazoline derivatives as EGFR inhibitors and apoptosis inducers. Amin NH; Elsaadi MT; Zaki SS; Abdel-Rahman HM Bioorg Chem; 2020 Dec; 105():104358. PubMed ID: 33074119 [TBL] [Abstract][Full Text] [Related]
54. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability. Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors. Ravula P; Vamaraju HB; Paturi M; Sharath Chandra JNGN Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29205467 [TBL] [Abstract][Full Text] [Related]
56. Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment. Ryad N; Elmaaty AA; M Ibrahim I; Ahmed Maghrabi AH; Yahya Alahdal MA; Saleem RM; Zaki I; Ghany LMAA Future Med Chem; 2024; 16(11):1087-1107. PubMed ID: 38722235 [TBL] [Abstract][Full Text] [Related]
57. Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF Abou-Zied HA; Beshr EAM; Gomaa HAM; Mostafa YA; Youssif BGM; Hayallah AM; Abdel-Aziz M Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200464. PubMed ID: 36526595 [TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR Al-Wahaibi LH; Mohammed AF; Abdel Rahman FES; Abdelrahman MH; Gu X; Trembleau L; Youssif BGM J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2218602. PubMed ID: 37254958 [TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFR Ding S; Dong X; Gao Z; Zheng X; Ji J; Zhang M; Liu F; Wu S; Li M; Song W; Shen J; Duan W; Liu J; Chen Y Bioorg Chem; 2022 Jan; 118():105471. PubMed ID: 34798457 [TBL] [Abstract][Full Text] [Related]
60. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2. Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]